Constellation Pharmaceuticals, Inc.
(NASDAQ : CNST)

( )
CNST After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
-0.27%63.771.4%$1734.36m
JNJJohnson & Johnson
0.07%141.440.7%$888.04m
PFEPfizer Inc.
-0.55%38.330.9%$745.36m
MRKMerck & Co., Inc.
0.32%89.240.7%$681.24m
ABBVAbbVie, Inc.
-1.07%87.782.3%$606.93m
LLYEli Lilly & Co.
-0.14%121.531.1%$363.78m
NVSNovartis AG
0.25%93.290.2%$148.80m
AZNAstraZeneca Plc
0.92%48.361.2%$138.82m
GSKGlaxoSmithKline Plc
0.13%45.990.2%$135.62m
RETAReata Pharmaceuticals, Inc.
2.84%206.753.5%$115.81m
SNYSanofi
0.57%49.790.2%$108.98m
KRTXKaruna Therapeutics, Inc.
-11.24%65.250.0%$103.88m
NVONovo Nordisk A/S
1.33%57.250.1%$91.99m
ALLKAllakos, Inc.
-2.21%123.190.0%$74.48m
FTSVForty Seven, Inc.
-7.72%35.750.0%$49.11m

Company Profile

Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The company utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product candidates include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.